Where the global biotech industry comes to partner.
The twelfth annual BIO-Europe Spring® conference is the premier springtime partnering conference for the biotechnology industry. For its 2018 edition, BIO-Europe Spring comes to Amsterdam, The Netherlands on March 12–14, 2018.
The conference annually attracts the international “who’s who” from biotech, pharma and finance for three days of high caliber networking. BIO-Europe Spring’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Attend BIO-Europe Spring and experience how you can have more partnering meetings in the three days of the conference than in the rest of the year.
Based on attendance at previous events, BIO-Europe Spring 2018 will bring together close to 2,600 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in over 15,000 partnering meetings.
Partnering at BIO-Europe Spring is powered by partneringONE®, the leading conference solution for helping life science delegates meet efficiently and effectively. partneringONE has the unique ability to manage the complex interactions between thousands of executives from many different companies.
This sophisticated web-based partnering system enables delegates to screen potential partners, pre-arrange meetings and manage the entire conference partnering process.
Delegates can login and connect with the conference community, anytime, anywhere.
Producer:
EBD GmbH
Supported by:
Biotechnology Innovation Organization (BIO)
Contact:Catharine Moreno Finan
EBD Group
In Europe: +49 89 23 88 756 25
In the USA: +1 760 930 0500
cmoreno@ebdgroup.com
Website:https://ebdgroup.knect365.com/bioeurope-spring/
Industry:
Biotech
Pharma
Medtech
Medical devices
Key words:
partnering, business development, biotech, pharmaceutical, medical device, medtech, diagnostic, licensing, finance
Intended for:
Executives from:
• Established and emerging biotech and medtech companies
• Pharmaceutical companies
• Institutional financial firms
• Private investors including venture capital and private equity firms
• Other industry related service companies
Cost:
Please see website:https://ebdgroup.knect365.com/bioeurope-spring/registration-information
Program:
Please see website:https://ebdgroup.knect365.com/bioeurope-spring/agenda/2
Date:March 12–14, 2018
Venue address:
RAI Amsterdam
Europaplein
NL 1078 GZ Amsterdam
The Netherlands
Venue website:https://www.rai.nl/en/
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.